Regarding cortex, there were no significant differences between the melatonin-treated groups in BAD cortical levels; in the case of BAX, the pre-ischemia treatment achieved a significantly higher decrease in the contralateral (left) hemisphere (p < 0.01). The gene discussed is BAX; the disease is ischemia.